Oxford PharmaGenesis
Generated by Meeveem AI
"An independent HealthScience consultancy accelerating evidence-based innovations for patients."
Oxford
•501 - 1000 Employees
•Health Advisory
About Oxford PharmaGenesis
Oxford PharmaGenesis partners with pharmaceutical companies, medical device firms and healthcare organisations to communicate evidence-based innovations in areas of unmet medical need. The consultancy provides strategic expertise across medical communications, medical affairs, value demonstration and publications. Founded in 1998, it now employs more than 500 specialists working globally. The company translates clinical evidence into compelling communications for physicians, regulators, payers and patients. Oxford PharmaGenesis combines deep therapeutic expertise with innovative tools. Independent ownership allows the team to prioritise long term client relationships and scientific rigour.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
500
Team Members
1998
Founded
Private Equity
Funding
Hybrid
Work Environment
Our Vision
A healthcare system where evidence-based innovations reach patients rapidly, where scientific rigour drives decisions, and where unmet medical needs are addressed through clear, credible communication accessible to all stakeholders.
Our Mission
To accelerate adoption of evidence-based innovations for patients in areas of unmet medical need.